AU Patent
AU7490600A — Inhibiting t-cell proliferation
Assigned to Biocryst Pharmaceuticals Inc · Expires 2001-04-17 · 25y expired
What this patent protects
Patent listed against Veklury.
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.